Highlights BioSyent Inc.

Equities

RX

CA0906901081

Market Closed - Toronto S.E. Other stock markets 15:58:43 2024-06-21 EDT			5-day change	1st Jan Change
10.5 ^CAD	+4.90%		+10.41%	+13.88%

05-17	Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	CI
05-17	BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Ex-dividend day	05-30	FA
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	05-16	CI
BioSyent Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-16	CI
BioSyent Inc Declares Second Quarter 2024 Dividend, Payable June 15, 2024	05-16	CI
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.	03-13	CI
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2023.	03-13	CI
BioSyent Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-13	CI
BioSyent Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-13	CI
BioSyent Inc. Seeks Acquisitions	03-12	CI
Ex-dividend day	02-27	FA
BioSyent Declares First Quarter 2024 Dividend	02-06	MT
BioSyent Inc. Declares First Quarter 2024 Dividend, Payable on March 15, 2024	02-06	CI
BioSyent Inc.'s Equity Buyback announced on December 13, 2022, has expired with 380,000 shares, representing 3.17% for CAD 2.89 million.	12-17	CI
BioSyent Inc. (TSXV:RX) announces an Equity Buyback for 650,000 shares, representing 5.53% of its issued share capital.	12-13	CI
BioSyent Inc. authorizes a Buyback Plan.	12-12	CI
Ex-dividend day	11-28	FA
Biosyent Reports Q3 2023 Results	11-16	MT
Tranche Update on BioSyent Inc. (TSXV:RX)'s Equity Buyback Plan announced on December 13, 2022.	11-16	CI
BioSyent Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-16	CI
BioSyent Inc. Declares Fourth Quarter 2023 Dividend, Payable on December 15, 2023	11-15	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights BioSyent Inc.

Equities

RX

CA0906901081

Highlights

Filters